Geode Capital Management LLC Has $206.61 Million Position in Encompass Health Corporation $EHC

Geode Capital Management LLC boosted its holdings in Encompass Health Corporation (NYSE:EHC) by 7.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,946,134 shares of the company’s stock after buying an additional 137,892 shares during the period. Geode Capital Management LLC’s holdings in Encompass Health were worth $206,605,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of EHC. EP Wealth Advisors LLC raised its position in shares of Encompass Health by 2.4% in the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after acquiring an additional 88 shares during the period. Allworth Financial LP raised its position in shares of Encompass Health by 14.7% in the 3rd quarter. Allworth Financial LP now owns 701 shares of the company’s stock valued at $89,000 after acquiring an additional 90 shares during the period. Westside Investment Management Inc. raised its position in shares of Encompass Health by 56.7% in the 3rd quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock valued at $35,000 after acquiring an additional 101 shares during the period. Leuthold Group LLC raised its position in shares of Encompass Health by 0.3% in the 4th quarter. Leuthold Group LLC now owns 31,168 shares of the company’s stock valued at $3,308,000 after acquiring an additional 104 shares during the period. Finally, Covestor Ltd raised its position in shares of Encompass Health by 24.4% in the 4th quarter. Covestor Ltd now owns 540 shares of the company’s stock valued at $57,000 after acquiring an additional 106 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

EHC has been the topic of a number of analyst reports. Leerink Partners set a $152.00 price target on shares of Encompass Health in a research report on Friday, May 22nd. Barclays cut their price target on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, TD Cowen initiated coverage on shares of Encompass Health in a research report on Thursday, May 28th. They issued a “buy” rating and a $125.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $142.75.

Insider Activity at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 682 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $104.56, for a total transaction of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This trade represents a 2.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Treasurer Edmund Fay sold 11,937 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $107.00, for a total transaction of $1,277,259.00. Following the sale, the treasurer owned 89,325 shares in the company, valued at $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.80% of the company’s stock.

Encompass Health Stock Performance

Shares of EHC stock opened at $101.53 on Wednesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.17 and a current ratio of 1.17. The company has a market capitalization of $10.07 billion, a P/E ratio of 16.95, a price-to-earnings-growth ratio of 2.24 and a beta of 0.72. The company’s 50 day moving average price is $103.40 and its two-hundred day moving average price is $105.28. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99.

Encompass Health (NYSE:EHC) last announced its earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping the consensus estimate of $1.51 by $0.09. The firm had revenue of $1.59 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The business’s quarterly revenue was up 9.0% on a year-over-year basis. During the same period last year, the company posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, analysts expect that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is 12.69%.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.